SCHEMBL3267992

SCHEMBL3267992

CCC[C@H]1CC[C@H](c2ccc(C(=O)O)cc2)CC1

nearest known ligand 0.75

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.75
ALDH1A1 P00352 2/20 0.71
LMNA P02545 1/20 0.71
MAPT P10636 1/20 0.71
MEN1 O00255 1/20 0.62
MAPK1 P28482 1/20 0.62
KMT2A Q03164 1/20 0.62
ESR2 Q92731 3/20 0.46
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
DGAT1 O75907 5/20 0.41
ESR1 P03372 1/20 0.41
CYP3A4 P08684 1/20 0.41
HAO1 Q9UJM8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770921 1.00 CYP2C9 (0.75) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL10730169 0.95 CYP2C9 (0.69) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL10730158 0.95 CYP2C9 (0.69) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL7722697 0.95 CYP2C9 (0.69) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL7722701 0.95 CYP2C9 (0.69) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL7722695 0.95 CYP2C9 (0.69) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL22564676 0.94 CYP2C9 (0.68) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL14548245 0.92 CYP2C9 (0.64) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL5888896 0.91 CYP2C9 (0.62) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL10554235 0.91 CYP2C9 (0.62) CYP2C9ALDH1A1LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115109600-B Diamine compound and preparation method and application thereof 波米科技有限公司 2023-11-28 CN claimed
CN-115109600-A Diamine compound and preparation method and application thereof 波米科技有限公司 2022-09-27 CN claimed
JP-5255194-A None JP disclosed
EP-4538305-A1 ATROPISOMER OF 1,1`-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOUND, OPTICAL FILM, IMPAGE DISPLAY DEVICE, AND EYEWEAR Nippon Kayaku Kabushiki Kaisha (JP) 2025-04-16 EP disclosed
US-20250101307-A1 ATROPISOMER OF 1,1'-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL FILM, IMAGE DISPLAY DEVICE, AND EYEWEAR NIPPON KAYAKU KK (JP) 2025-03-27 US disclosed
CN-119301164-A Atropisomers of 1,1' -binaphthyl derivatives, polymerizable liquid crystal compositions, optical films, image display devices and glasses 日本化药株式会社 2025-01-10 CN disclosed
WO-2023243408-A1 ATROPISOMER OF 1,1'-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOUND, OPTICAL FILM, IMPAGE DISPLAY DEVICE, AND EYEWEAR 日本化薬株式会社 2023-12-21 WO disclosed
CN-115109600-B Diamine compound and preparation method and application thereof 波米科技有限公司 2023-11-28 CN disclosed
CN-115109600-A Diamine compound and preparation method and application thereof 波米科技有限公司 2022-09-27 CN disclosed
EP-2199270-B1 LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2016-05-25 EP disclosed
US-8580142-B2 Liquid crystal compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2013-11-12 US disclosed
JP-H05255194-A ESTER DERIVATIVE CITIZEN WATCH CO LTD 1993-10-05 JP disclosed
US-5200110-A Electro-optical displays; heat resistance, dielectrics, low driving voltage, dielectrics SEIKO EPSON CORPORATION (JP) 1993-04-06 US disclosed
EP-0391591-A2 Pyrimidine derivative and liquid crystal composition incorporating the same SEIKO EPSON CORPORATION (JP) 1990-10-10 EP disclosed
EP-0136480-B1 2,3-DICYANO-5-SUBSTITUTED PYRAZINES AND LIQUID CRYSTAL COMPOSITION CONTAINING THEM Chisso Corporation (JP) 1990-01-17 EP disclosed
US-4592857-A Containing a substituted phenyl ring in position 5 CHISSO CORPORATION (JP) 1986-06-03 US disclosed
EP-0136480-A2 2,3-Dicyano-5-substituted pyrazines and liquid crystal composition containing them Chisso Corporation (JP) 1985-04-10 EP disclosed
US-4487954-A LIQUID CRYSTALS CHISSO CORPORATION (JP) 1984-12-11 US disclosed
US-4419263-A Liquid crystalline cyclohexylcarbonitrile derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-12-06 US disclosed
US-4400293-A Liquid crystalline cyclohexylphenyl derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101307-A1 ATROPISOMER OF 1,1'-BINAPHTHYL DERIVATIVE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL FILM, IMAGE DISPLAY DEVICE, AND EYEWEAR ACVRL1, AMY1A, PARL CYP2C9 1252/4885ALDH1A1 2894/4885LMNA 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.